Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Juncos, Puerto Rico - Wikipedia

   en.wikipedia.org/wiki/Juncos,_Puerto_Rico

   Juncos, Puerto Rico. /  18.22750°N 65.92111°W  / 18.22750; -65.92111. Juncos ( Spanish pronunciation: [ˈxuŋkos]) is a town and one of the 78 municipalities of Puerto Rico. It is located in the eastern central region of the island to the west of the Caguas Valley, south of Canóvanas and Carolina; southeast of Gurabo; east of San ...

3. Amgen - Wikipedia

   en.wikipedia.org/wiki/Amgen

   Amgen Inc. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5] The name "AMGen" is a portmanteau of the ...

4. Kevin W. Sharer - Wikipedia

   en.wikipedia.org/wiki/Kevin_W._Sharer

   Kevin W. Sharer (born March 2, 1948), is an American businessman who was chairman/CEO of the biotechnology company Amgen from 2000 to 2012. He later joined the faculty of Harvard Business School teaching RC Strategy and General Management. [1] [2] [3]

5. Amgen's peek at its GLP-1 drug trial results heightens ... - AOL

   www.aol.com/finance/amgens-peek-glp-1-drug...

   Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday.CEO Bob Bradway shared a peek at phase II results of the ...

6. US FDA approves Amgen drug for small cell lung cancer - AOL

   www.aol.com/news/us-fda-approves-amgen-drug...

   The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...

7. Where Will Amgen Be in 5 Years? - AOL

   www.aol.com/where-amgen-5-years-121500370.html

   June 20, 2024 at 8:15 AM. Amgen (NASDAQ: AMGN) is a top drugmaker whose shares have risen by more than 70% in five years, which is a bit shy of the S&P 500 's 90% gain over that stretch. With some ...

8. Amgen Inc v. Sanofi - Wikipedia

   en.wikipedia.org/wiki/Amgen_Inc_v._Sanofi

   Laws applied. Patent Act of 1952. Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering drugs failed to satisfy the enablement clause of §112 of the Patent Act, 35 U.S.C. § 112 (a). [1]

9. Amgen Seeks Expanded US Approval For Autoimmune Disease ... - AOL

   www.aol.com/finance/amgen-seeks-expanded-us...

   Amgen added Uplizna via a $27.8 billion acquisition of Horizon Therapeutics and recorded sales of $80 million in the first quarter of 2024. The trial met its primary endpoint, showing a ...